Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Håkon Bøås

Norwegian Institute of Public Health

Norway

This profile is automatically generated from trusted academic sources.

Google Scholar

.

ORCID

.

LinkedIn

Social connections

How do I reach out?

Sign in for free to see their profile details and contact information.

Meet Kite AI

Contact this professor

LinkedIn

ORCID Google Scholar

Research Interests

Epidemiology

100%

Virology

70%

Respiratory Infection

70%

Covid-19

60%

Sars-cov-2

60%

Pediatric

40%

Pandemic Preparedness

40%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles18

Changed epidemiology of influenza and RSV hospitalizations after the emergence of SARS-CoV-2 in Norway, 2017–2024

Year:

2025

Surveillance of severe acute respiratory infections associated with SARS-CoV-2, influenza virus and RSV using ICD-10 codes: a case definition accuracy study across five European countries, 2021 to 2023

Year:

2025

Registry‐Based Surveillance of Severe Acute Respiratory Infections in Norway During 2021–2024

Year:

2025

Healthcare associated COVID-19 Infections and Mortality

Year:

2025

Effectiveness of one and two doses of acellular pertussis vaccines against laboratory-confirmed pertussis requiring hospitalisation in infants: Results of the PERTINENT sentinel surveillance system in six EU/EEA countries, December 2015 – December 2019

Year:

2024

Increase in invasive group A streptococcal infections (iGAS) in children and older adults, Norway, 2022 to 2024

Year:

2024

No association between disease severity and respiratory syncytial virus subtypes RSV-A and RSV-B in hospitalized young children in Norway

Year:

2024

Frequency and risk of SARS-CoV-2 reinfections in Norway: a nation-wide study, February 2020 to January 2022

Year:

2024

Estimation of the number of RSV-associated hospitalisations in adults in the European Union

Year:

2023

Effectiveness of BNT162b2 vaccine against SARS-CoV-2 Delta and Omicron infection in adolescents, Norway, August 2021 to January 2022

Year:

2023

Stroke After SARS-CoV-2 mRNA Vaccine: A Nationwide Registry Study

Year:

2023

New perspectives on respiratory syncytial virus surveillance at the national level: lessons from the COVID-19 pandemic

Year:

2023

Short-term safety of COVID-19 mRNA vaccines with respect to all-cause mortality in the older population in Norway

Year:

2022

The burden of hospital-attended influenza in Norwegian children

Year:

2022

Risk factors associated with severe disease in respiratory syncytial virus infected children under 5 years of age

Year:

2022

COVID-19 Hospitalization Among Children <18 Years by Variant Wave in Norway

Year:

2022

Milder disease trajectory among COVID-19 patients hospitalised with the SARS-CoV-2 Omicron variant compared with the Delta variant in Norway

Year:

2022

Age-Specific Estimates of Respiratory Syncytial Virus-Associated Hospitalizations in 6 European Countries: A Time Series Analysis

Year:

2022

Collaborators5

Jacob Dag Berild

Norwegian Institute of Public Health

NORWAY

Pascale Renée Cyr

Norwegian Institute of Public Health

NORWAY

Lesly María Acosta Argueta

Profesora lectora

Universitat Politècnica de Catalunya

SPAIN

Lance Presser

Rijksinstituut voor Volksgezondheid en Milieu

NETHERLANDS

Hinta Meijerink

Norwegian Institute of Public Health

NORWAY

Social connections

How do I reach out?

Sign in for free to see their profile details and contact information.

Meet Kite AI